Correlation Between Antibe Therapeutics and Arch Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Antibe Therapeutics and Arch Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antibe Therapeutics and Arch Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antibe Therapeutics and Arch Therapeutics, you can compare the effects of market volatilities on Antibe Therapeutics and Arch Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antibe Therapeutics with a short position of Arch Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antibe Therapeutics and Arch Therapeutics.

Diversification Opportunities for Antibe Therapeutics and Arch Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Antibe and Arch is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Antibe Therapeutics and Arch Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Therapeutics and Antibe Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antibe Therapeutics are associated (or correlated) with Arch Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Therapeutics has no effect on the direction of Antibe Therapeutics i.e., Antibe Therapeutics and Arch Therapeutics go up and down completely randomly.

Pair Corralation between Antibe Therapeutics and Arch Therapeutics

If you would invest  18.00  in Arch Therapeutics on December 1, 2024 and sell it today you would earn a total of  5.00  from holding Arch Therapeutics or generate 27.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Antibe Therapeutics  vs.  Arch Therapeutics

 Performance 
       Timeline  
Antibe Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Antibe Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Antibe Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Arch Therapeutics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Arch Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Arch Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Antibe Therapeutics and Arch Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Antibe Therapeutics and Arch Therapeutics

The main advantage of trading using opposite Antibe Therapeutics and Arch Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antibe Therapeutics position performs unexpectedly, Arch Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Therapeutics will offset losses from the drop in Arch Therapeutics' long position.
The idea behind Antibe Therapeutics and Arch Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance